about
Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for TreatmentProfile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy.Application of the Immunoscore as prognostic tool for hepatocellular carcinoma.Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.lncRNA in HNSCC: challenges and potential.Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Immunotherapy for head and neck squamous cell carcinoma
@ast
Immunotherapy for head and neck squamous cell carcinoma
@en
Immunotherapy for head and neck squamous cell carcinoma
@nl
type
label
Immunotherapy for head and neck squamous cell carcinoma
@ast
Immunotherapy for head and neck squamous cell carcinoma
@en
Immunotherapy for head and neck squamous cell carcinoma
@nl
prefLabel
Immunotherapy for head and neck squamous cell carcinoma
@ast
Immunotherapy for head and neck squamous cell carcinoma
@en
Immunotherapy for head and neck squamous cell carcinoma
@nl
P2860
P3181
P1476
Immunotherapy for head and neck squamous cell carcinoma
@en
P2093
Thorsten Fuereder
P2860
P2888
P3181
P356
10.1007/S12254-016-0270-8
P407
P577
2016-01-01T00:00:00Z
P6179
1013057180